One Financial Statements From 2010 to 2025

OWPC Stock  USD 0.02  0.0003  1.57%   
One World's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing One World's valuation are provided below:
One World Pharma does not presently have any trending fundamental ratios for analysis.
Check One World financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among One World's main balance sheet or income statement drivers, such as , as well as many indicators such as . One financial statements analysis is a perfect complement when working with One World Valuation or Volatility modules.
  
This module can also supplement various One World Technical models . Check out the analysis of One World Correlation against competitors.

One World Pharma OTC Stock Return On Equity Analysis

One World's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current One World Return On Equity

    
  -4.13  
Most of One World's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, One World Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, One World Pharma has a Return On Equity of -4.133. This is 82.76% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.

One World Pharma Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining One World's current stock value. Our valuation model uses many indicators to compare One World value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across One World competition to find correlations between indicators driving One World's intrinsic value. More Info.
One World Pharma is regarded second in return on equity category among its peers. It is regarded fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value One World by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for One World's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About One World Financial Statements

One World stakeholders use historical fundamental indicators, such as One World's revenue or net income, to determine how well the company is positioned to perform in the future. Although One World investors may analyze each financial statement separately, they are all interrelated. For example, changes in One World's assets and liabilities are reflected in the revenues and expenses on One World's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in One World Pharma. Please read more on our technical analysis and fundamental analysis pages.
One World Products, Inc. intends to produce raw cannabis and hemp plant ingredients. One World Products, Inc. is headquartered in Las Vegas, Nevada. One World operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 31 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in One OTC Stock

One World financial ratios help investors to determine whether One OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in One with respect to the benefits of owning One World security.